MD Biosciences conducts cell-based assays for screening and mechanism of action studies using primary or immortalized cell lines. Our scientific team works with you to determine the best assay design for your needs. Our assay development experience crosses a broad range of study targets, and each test study is customized for sponsor relevance by choosing the correct cell system, stimulant, time point(s) and end readouts that fit the objectives of the study. While a majority of studies use either patient-derived PBMC's or established cell lines such as macrophage U937 or RAW264.7 cells, HUVEC endothelial cells, A549 alveolar cells or neuronal cells, virtually any cell type would be possible to establish and use in studies.
Speak to us today about your particular study needs.
|Example Cell Systems:||Example Readouts||Example ex vivo* cell subsets|
|Primary PBMCs||Cell viability||Bronchiolar lavage cells|
|Human Macrophage cell line (U937)||Biomarkers (quantitative PCR, multiplexed protein or ELISA)||Tumor-infiltrating lymphocytes|
|Mouse Macrophage cell line (RAW264.7)||Cell proliferation||Blood cells|
|HUVEC Endothelial cells||Cell stimulation/activation||Splenocytes|
|A549 Alveolar epithelial cells||Cellular invasion/migration||Lymphocytes from draining or non-draining lymph nodes|
|Primary rat dorsal root ganglia (DRGs)||Immuno and cellular phenotyping (multi-color flow cytometry)||Tissue specific cells|
|Primary rat cortical and hippocampal neurons|
|Several human and mouse cancer cell lines|
*ex vivo analyses can be performed on cells isolated from animals involved in preclinical studies.
The above list is a small sampling of the available assays. Contact a scientist today to discuss a cell-based assay test that can meet your primary objectives.